Protecting Global Health. Defending Military Readiness.

From emerging threats to persistent pathogens, Geneva advances infectious disease research that detects, prevents, and responds across diverse operational environments. By developing rapid diagnostics, novel vaccines, and antimicrobial resistance strategies, we strengthen force health protection and ensure service members remain ready and resilient wherever they serve—while also contributing to global health security.

Why Infectious Disease Research Matters

Infectious diseases are among the most significant threats to military effectiveness, undermining both the health of service members and mission success:

• • High Burden of Disease: Infectious diseases account for a substantial number of military hospital admissions, often surpassing battlefield injuries.

  • Future Operational Risks: Weakened environmental barriers and dense urban populations heighten the risk of rapid infectious disease spread, threatening global stability and readiness.

  • Wound Infections: In prolonged care settings, infections can delay recovery and reduce the operational effectiveness of military personnel.

The Geneva Advantage

With deep DoD expertise and agile contracting infrastructure, Geneva accelerates infectious disease research from discovery to deployment—delivering mission-ready solutions that protect service members and strengthen global health.

• • Access to Cutting-Edge Facilities: Leveraging BSL-3 and BSL-4 laboratories for advanced vector-borne disease research, Geneva ensures precision and safety in studying high-consequence pathogens.

  • Strategic Collaborations: Partnerships with leading federal and military research institutes—including USAMRIID, Walter Reed Army Institute of Research, and AFRIMS—drive innovation and expand global reach.

  • Expert Guidance: Geneva’s Scientific Advisory Board provides critical oversight and expertise to ensure innovative, impactful strategies address the most urgent infectious disease threats.